Anupama Grandhi

Anupama Grandhi, BDS, DDS, serves as Associate Professor in Oral and Maxillofacial Surgery at Loma Linda University School of Dentistry and Assistant Professor in Pathology and Human Anatomy at the School of Medicine. Her dual appointment bridges dental and medical pathology through interdisciplinary research and clinical education.

Her educational foundation includes:

• Bachelor of Dental Surgery (BDS) from Rajiv Gandhi University of Health Sciences (2002)
• Doctor of Dental Surgery (DDS) from University of Southern California (2006)

Dr. Grandhi's research pioneers AI-integrated approaches to oral cancer and dysplasia, focusing on epigenomic/transcriptomic signatures and noninvasive diagnostics. She investigates perineural invasion mechanisms and biomaterial effects on neural tissues, with recent work developing brush swab techniques as alternatives to tissue biopsies. Her methodology combines computational analysis with molecular biology to advance early detection and precision oncology in dentistry.

Analysis of her 2021-2024 publications reveals accelerating interdisciplinary output (3 papers in 2024 alone), with dominant themes in AI-driven diagnostics, multi-omics integration for tobacco-related cancer signatures, and clinical translation of noninvasive methods. This trajectory positions her at the forefront of computational oral pathology.

Her professional recognitions include:

• Diplomate, American Board of Oral and Maxillofacial Pathology (2012-present)
• Fellow, American Academy of Oral and Maxillofacial Pathology (2012-present)
• Fellow, Southern California Academy of Oral Pathology (2017-present)

Dr. Grandhi actively secures research funding through industry partnerships, currently leading two Vigilant Biosciences clinical studies: the BEVIGILANT™ ORAFUSION SYSTEM trial (2023) and OncAlert RAPID evaluation (2024). While specific student names aren't published, her collaborative publications indicate active mentorship of trainees across dental and medical disciplines. Her teaching portfolio demonstrates consistent commitment to clinical oral pathology education through courses like GRDN 535 and DENT 880.

Though no formal lab name is designated, her research group operates at the convergence of oral oncology, computational pathology, and translational diagnostics, driving innovation in cancer detection methodologies and neural-tumor interaction studies.